February 21, 2017

Canon Inc.

Chairman & CEO: Fujio Mitarai Securities code: 7751

Tokyo (First section) and other Stock Exchanges

Inquiries: Eiji Shimizu

General Manager

Consolidated Accounting Division Group Management Center

Finance & Accounting Headquarters

+81-3-3758-2111

Notice Concerning Acquisition of Toshiba Medical Finance Co., Ltd. Shares and Making it a Subsidiary

Canon Inc. ("Canon") gives notice that as of today, it has decided to acquire the shares of Toshiba Medical Finance Co., Ltd. ("TMF") from Toshiba Corporation ("Toshiba") and make TMF a subsidiary.

  1. Reason for Acquisition

    Under Phase V of its Excellent Global Corporation Plan, a five-year initiative launched in 2016, Canon aims to embrace the challenge of new growth through a grand strategic transformation. With regard to reinforcing and expanding new businesses in particular, which represents one of the important strategies to be carried out during this phase, Canon intends to cultivate its health care business within the safety and security sector as a next-generation pillar of growth.

    As part of this initiative, Canon acquired the shares of Toshiba Medical Systems Corporation ("TMSC") on December 19, 2016 and made TMSC a subsidiary. TMSC holds 35% of the share of TMF, a company that is involved in the leasing of medical and other equipment. By acquiring the remaining 65% and making TMF a subsidiary, Canon plans to accelerate growth of its medical equipment business, building a collaborative organization from a TMSC and TMF marketing perspective.

  2. Overview of Transaction
  1. Overview of Subsidiary That is Being Sold

    (1)

    Name

    Toshiba Medical Finance Co., Ltd.

    (2)

    Address

    14-10 Ningyo-cho 2-chome, Nihombashi, Chuo-ku, Tokyo

    (3)

    Name and Title of Representative

    Shohei Seki, President & CEO

    (4)

    Business Outline

    Lease and credit sales of medical equipment

    (5)

    Capital Stock

    120 million yen

    (6)

    Established

    September 1, 1970

    (7)

    Major Shareholders and Shareholding Ratios

    Toshiba Corporation 65%

    Toshiba Medical Systems Corporation 35%

    (8) Relationship between Canon and TMF

    Capital

    Canon holds 35% of TMF's common shares indirectly through TMSC, a subsidiary of Canon.

    Personnel

    One director of TMSC concurrently serves as a director of TMF. In addition, 10 employees of TMSC are currently on temporary transfer to TMF.

    Business

    TMF purchases medical equipment from TMSC, and is leasing vehicles for TMSC.

    (9) Operating Performance and Financial Condition in the Last Three Fiscal Years

    Fiscal Years

    FY2013

    FY2014

    FY2015

    Net Assets (Equity)

    4,904 million yen

    5,030 million yen

    5,215 million yen

    Total Assets

    48,547 million yen

    49,817 million yen

    48,692 million yen

    Shareholder's Equity per Share

    20,437 yen

    20,959 yen

    21,729 yen

    Net Sales

    15,521 million yen

    15,436 million yen

    15,259 million yen

    Operating Income

    540 million yen

    427 million yen

    456 million yen

    Recurring Profit

    539 million yen

    426 million yen

    453 million yen

    Net Income (Loss)

    329 million yen

    257 million yen

    287 million yen

    Net Income (Loss) per Share

    1,373.60 yen

    1,072.75 yen

    1,199.42 yen

    Dividend per Share

    550.00 yen

    430.00 yen

    420.00 yen

  2. Overview of Counterparty From Which Shares are Being Acquired

    (1) Name

    Toshiba Corporation

    (2) Address

    1-1 Shibaura 1-chome, Minato-ku, Tokyo

    (3) Name and Title of Representative

    Satoshi Tsunakawa, Representative Executive Officer, President & CEO

    (4) Business Outline

    Businesses in Energy Systems & Solutions, Infrastructure Systems & Solutions, Retail & Printing Solutions, Storage & Electronic Devices Solutions, and Industrial ICT Solutions

    (5) Capital Stock

    200,000 million yen (End of September 2016)

    (6) Established

    June 25, 1904

    (7) Net Assets

    698,116 million yen (End of September 2016)

    (8) Total Assets

    4,832,782 million yen (End of September 2016)

    (9) Major Shareholders and Shareholding Ratios

    JP MORGAN CHASE BANK 380055 4.1%

    The Master Trust Bank of Japan, Limited (trust account) 3.8% Japan Trustee Services Bank, Limited (trust account) 2.9% (As of the end of September 2016)

    (10) Relationship between Canon and Toshiba

    Capital

    As of December 31, 2015, Canon held 6,398 thousand shares or 0.15% of Toshiba's outstanding shares.

    Personnel

    None

    Business

    Canon procures memory, IC and other semiconductor parts from Toshiba. Additionally, Canon sells semiconductor lithography equipment to Toshiba.

    Status as to Related Parties

    None

  3. No. of Shares Being Acquired, the Acquisition Price, and the Situation of Share Holding Before and After Acquisition

    (1) No. of Shares Held Before the Transfer

    84,000 shares (Held by TMSC) (Number of voting rights: 84,000),

    (Ratio of ownership voting rights: 35.0%)

    (2) Number of Shares to be Acquired

    156,000 shares

    (Number of voting rights: 156,000)

    (3) Acquisition Price

    3.14 billion yen (Note 1)

    (4) Number of Shares to be Held After the Transfer

    240,000 shares

    (Number of voting rights: 240,000), (Ratio of ownership voting rights: 100%)

    Note 1: Canon judged the acquisition price to be reasonable, after conducting an in-depth study of TMF's business and other details and considering the advice of Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Canon's financial advisor.

  4. Schedule

Date of determination

February 21, 2017

Date of agreement signing

February 21, 2017

Date of stock acquisition (Tentative)

March 31, 2017

3. Outlook

As for the impact this will have on the company's performance, in cases where the company needs to revise its projection it will make prompt disclosure. The company will also make prompt disclosure when something that needs to be made public occurs.

This notice contains forward-looking statements with respect to future results, performance and achievements that are subject to risk and uncertainties and reflect management's views and assumptions formed by available information. All statements other than statements of historical fact are statements that could be considered forward-looking statements. When used in this document, words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "project" or "should" and similar expressions, as they relate to Canon, are intended to identify forward-looking statements. Many factors could cause the actual results, performance or achievements of Canon to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, changes in general economic and business conditions, changes in currency exchange rates and interest rates, introduction of competing products by other companies, lack of acceptance of new products or services by Canon's targeted customers, inability to meet efficiency and cost-reduction objectives, changes in business strategy and various other factors, both referenced and not referenced in this notice. A detailed description of these and other risk factors is included in Canon's annual report on Form 20-F, which is on file with the United States Securities and Exchange Commission. Should one or more of these

risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. Canon does not intend or assume any obligation to update these forward-looking statements.

Canon Inc. published this content on 21 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 February 2017 06:28:05 UTC.

Original documenthttp://www.canon.com/ir/release/2017/p2017feb21e.pdf

Public permalinkhttp://www.publicnow.com/view/F616A1E84DA13EA272F81A45BDE42203B5C4BFF6